Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord mesenchymal stem cells (Yantai Yuhuangding Hospital)
- Development stage
- Unknown
- Lead developer
- Yantai Yuhuangding Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
This investigational cell therapy, developed by Yantai Yuhuangding Hospital, utilizes human umbilical cord mesenchymal stem cells (UCMSCs) for the treatment of moderate to severe persistent allergic rhinitis. UCMSCs are characterized by their multilineage differentiation potential, high proliferative capacity, and low immunogenicity. The therapy functions through immunomodulatory mechanisms, secreting bioactive molecules that restore the Th1/Th2 immune balance and modulate inflammatory responses mediated by IgE antibodies and various immune cells. It is specifically being studied in patients with long-standing dust mite allergies who have failed conventional pharmacotherapy for more than two years.
- Other names
- UCMSCshUC-MSCs
Beyond the preview
Go deeper on human umbilical cord mesenchymal stem cells (Yantai Yuhuangding Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord mesenchymal stem cells (Yantai Yuhuangding Hospital).